Ophthalmology Doctors in Easton, PA Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Gabrielle Schoeppner, MD Ophthalmology - Glaucoma Specialist Medicare: Accepting Medicare Assignments Practice Location: 3735 Nazareth Rd, Suite 205, Easton, PA 18045 Phone: 610-258-7255    Fax: 610-258-5197

Dr. Brian Mckinley Willard, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1108 Van Buren Rd, Suite 202, Easton, PA 18045 Phone: 610-253-2968    Fax: 610-253-2516

James George Mcbride, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2061 Fairview Ave, Fairview Medical Building, Easton, PA 18042 Phone: 610-252-8162    Fax: 610-252-4013

James F Cochran, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2151 Fairview Avenue, Easton, PA 18042 Phone: 610-258-4334    Fax: 610-258-9418

Eric Postel, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 1872 St Lukes Blvd, Easton, PA 18045 Phone: 866-785-8537

Dr. Donald Earl Willard Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1901 Hay Ter, Easton, PA 18042 Phone: 610-253-9675    Fax: 610-253-4533

News Archive

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the crowded and highly fragmented European active pharmaceutical ingredients (API) market are struggling to overcome a variety of challenges. One of the most pressing of these is the problem of overcapacity.

Adiponectin is a metabolic link between obesity and bone mineral density

Researchers at the University of Toronto, Faculty of Medicine, Toronto, Canada, have discovered that adiponectin, a protein secreted from adipocytes, is a metabolic link that can explain, in part, the known positive relationship between obesity and both bone mineral density and reduced susceptibility to fractures.

CVBT seeks FDA 'fast track' designation for CVBT-141B to treat ischemic diabetic wounds

CardioVascular BioTherapeutics, Inc. today announced it has submitted an application to the U.S. FDA to obtain "fast track" designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1).

Genetic mutation that protects skin from UV radiation may cause testicular cancer in Caucasian

A Ludwig Cancer Research study published in Cell today identifies a common mutation that dramatically increases the risk for testicular cancer—and describes a likely molecular mechanism by which it exerts that effect.

Study highlights need for early identification, treatment of PTSD in cancer survivors

A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued to live with PTSD years later.

Read more Medical News

› Verified 7 days ago